Navigation Links
Dutch royal honors for Manchester researchers
Date:12/2/2010

They are now Knight Commanders in the Order of the Netherlands Lion the country's most prestigious award.

The academics, who won the 2010 Nobel Prize in Physics for their discovery of graphene, were handed the royal honour at a ceremony in Nijmegen in the Netherlands.

Professor Geim worked as an associate professor at The University of Nijmegen before 2001 and is a Dutch citizen.

Professor Novoselov received his PhD from Nijmegen in 2004. However it is very rare for a non-Dutch citizen, such as Professor Novoselov who is a dual Russian and British national, to be awarded the honour at such a high level.

The two professors, who work together at the University's School of Physics and Astronomy, discovered the world's thinnest and strongest material by tearing off tiny molecules of carbon from graphite.

Graphene can be used in thousands of applications from ultrafast transistors to composite materials for aeroplanes to touch screens and to new generations of electric batteries.

Dutch State Secretary Halbe Zijlstra presented the professors with their medals at a ceremony in the Netherlands.

Addressing Professor Geim, he said: " In scientific terms, you straddle different traditions. You were educated in Russia, you conducted considerable scientific work in the Netherlands, and you now work in Manchester, together with Konstantin Novoselov.

"You are living proof that science is an international field. In your career in science, you have moved around just as quickly as the electrons in graphene.

"The revolutionary scientific breakthroughs that have led to Nobel Prizes would, of course, not have been possible without academic freedom. Scientists must be given the freedom to come up with radical and unorthodox ideas.

"And we must accept the fact that research sometimes fails. Scientists must also be given the freedom to follow research to a dead end.

"Let me say it again: our country is extremely proud of you both. It is with enormous pleasure that I have the honour of informing you that Her Majesty, the Queen is pleased to bestow a Royal Honour on both of you and to induct you both as a Commander in the Order of the Netherlands Lion."

Professor Geim said: "It is a wonderful feeling to receive the honour that is normally reserved for Dutch-born Nobel laureates. As a Dutch citizen it gives me a real sense of pride for the Netherlands that as a Russian born is treated equally.

"I look back at my time in the Netherlands with great fondness and I was able to do some important work while I was there.

"This honour is a testament to the power of science and to its importance in the world today,."

Professor Novoselov added: "I enjoyed my years in the Netherlands, but, as I am not Dutch, I could never expect to receive such a very rare honour.

"I am shocked and delighted to have been recognized in this way. This is something I will treasure greatly."


'/>"/>

Contact: Daniel Cochlin
daniel.cochlin@manchester.ac.uk
0044-161-275-8387
University of Manchester
Source:Eurekalert

Related biology technology :

1. Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
2. Cell Therapeutics Amends Modified Dutch Auction Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes
3. Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
4. Cell Therapeutics Amends and Restates Its Modified Dutch Auction Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes
5. Dutch Biotech Company Pepscan Appoints New CEO
6. TPC Group Announces Commencement of Dutch Auction Tender Offer to Repurchase for Cash up to $130 Million in Common Stock
7. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
8. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
9. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
10. TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel
11. AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... February 9, 2016 Three-Year Initiative Supports ... to Take Part in Life-Changing Camp ... designed to positively affect the lives of children born with rare ... --> SHPG ) is announcing a new initiative designed to ... well as the future of rare disease care. --> ...
(Date:2/8/2016)... Feb. 8, 2016 Should antibiotic bone cement ... products to prevent infection after standard total hip or ... at ECRI Institute have been fielding a lot lately. ... Your Bottom Line?" --> "Antibiotic ... --> While there isn,t a ...
(Date:2/8/2016)... ... 08, 2016 , ... Thomas J. Todorow has joined the ... for Corporate Services and the Chief Financial Officer at The Children’s Hospital of ... Managed Care Contracting, Supply Chain, and Investments. , Prior to joining CHOP and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Franz Inc. , an ... technology, today announced the availability of AllegroGraph 6, the leading Semantic Graph Database ... Certified Technology Program (CCPT). AllegroGraph is the first Semantic Graph Database to ...
Breaking Biology Technology:
(Date:2/3/2016)... --> --> Fourth quarter 2015:   ... fourth quarter of 2014. Gross margin was 46% (32). ... Earnings per share increased to SEK 6.39 (loss: 0.49). Cash ... --> --> January to December ... 1,142% compared with 2014. Gross margin was 43% (31). ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):